This concept groups genes and proteins that specifically inhibit the formation of metastases. The review treats them as mechanistic entry points into the metastatic cascade and its regulation.
First-pass extracted concept
metastasis suppressor proteins
Extracted Explainers
What the tool is doing
Resources required
What problem it solves
What it does not solve
Evidence Snippets
Supporting Sources
Linked Claims
The review groups metastasis suppressors into four signaling categories: cytoskeletal signaling, mitogenic pathways, stress-activated pathways, and survival pathways.
Based on their known biochemical functions, we have divided the metastasis suppressors into four general signaling categories: cytoskeletal signaling, mitogenic pathways, stress-activated pathways, and survival pathways.
Metastasis suppressors are genes or proteins that inhibit metastasis without significantly affecting primary tumor growth.
These pioneering studies used an unbiased approach to identify such candidates by demonstrating that ectopic expression of the putative suppressor gene inhibited the development of spontaneous macroscopic metastases without significantly affecting primary tumor growth.
nm23 was the first metastasis suppressor gene and provided functional evidence that genes can specifically regulate metastasis.
The identification of nm23, the first metastasis suppressor gene, provided functional evidence for the existence of genes that specifically regulate metastasis.
Some metastasis suppressors inhibit metastatic colonization after dissemination and lodging at secondary sites rather than blocking primary tumor growth.
In vivo studies showed that metastatic cancer cells which express ectopic KISS1, JNKK1/MKK4, MKK6, MKK7, TXNIP, nm23-H1, or SSeCKS proteins could successfully disseminate and lodge at secondary sites, but are suppressed in their ability to colonize (i.e., form overt metastases) target tissues.
In vivo assays are required for identifying bona fide metastasis suppressor activity because in vitro assays are often too simple to model the full metastatic process and tissue-specific growth.
The use of in vivo assays is required because in vitro assays are often of inadequate complexity to sufficiently model the entire process of metastasis. Furthermore, there are currently no in vitro models that allow the study of preferential growth within different target tissues.
Current data support a model in which ectopic expression of metastasis suppressor proteins partially restores earlier endogenous signaling repertoires and thereby blocks metastasis formation.
Current data supports a model in which ectopic expression of metastasis suppressor proteins may restore, at least in part, the endogenous signaling repertoire of earlier, more benign cellular generations, thereby blocking metastasis formation.